FDA recall D-0753-2026

Product

SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02

Reason for recall

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Distribution

Nationwide within the U.S

Key facts

Status

Ongoing

Initiation date

2026-07-29

Report date

2026-08-19

Voluntary/Mandated

Voluntary: Firm initiated

Location

Columbia, MO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0753-2026